GeneOne Life Science Inc (011000) — Capital Reinvestment Ratio
Latest as of December 2021:
9.66x
GeneOne Life Science Inc (011000) has a Capital Reinvestment Ratio of 9.66x as of December 2021, meaning it reinvests 10% of its operating cash flow (₩3.67 Billion) in capital expenditures (₩35.40 Billion). See GeneOne Life Science Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
9.66x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.67 Billion
KRW
Capital Expenditures
₩35.40 Billion
KRW
Data as of
Dec 2021
Most recent filing
GeneOne Life Science Inc Capital Reinvestment Ratio (2015–2015)
This chart tracks GeneOne Life Science Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for GeneOne Life Science Inc (2015–2015)
Year-by-year Capital Reinvestment Ratio for GeneOne Life Science Inc from 2015 to 2015. For live market cap and broader valuation context, see GeneOne Life Science Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 2.62x | ₩778.50 Million | ₩2.04 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow